NCT06069128View on ClinicalTrials.gov

Evaluate the Usability of the Neuro-trigger Artificial Eye Blinking Stimulation Device in Patients With Paralysis of the Facial Nerve.

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

August 1, 2024

Study Completion Date

September 5, 2024

Conditions
ParalysisParalysis; EyeParalysis; Bell
Interventions
DEVICE

Neurotrigger Basic. eye blinking stimulator

NeuroTrigger Basic is intended to stimulate healthy muscles in order to improve or facilitate muscle performance for maintaining/increasing muscle range of motion and for the prevention or retardation of disuse atrophy.

Trial Locations (1)

Unknown

Tel Aviv Sourasky Medical Center (Ichilov), Tel Aviv

Sponsors

Lead Sponsor

Neurotrigger Ltd
All Listed Sponsors
lead

Neurotrigger Ltd

INDUSTRY

NCT06069128 - Evaluate the Usability of the Neuro-trigger Artificial Eye Blinking Stimulation Device in Patients With Paralysis of the Facial Nerve. | Biotech Hunter | Biotech Hunter